Faron, etusivu

releases and publications

BEXMAB study Update

Regulatory

Holding(s) in Company

Shareholder announcement Regulatory

Announcement of Placing

Regulatory

Exercise of options

Regulatory

New biomarker data from BEXMAB study at EHA2023

Board Member to Assume Transactional Advisor Role

Regulatory

Bexmarilimab Efficacy and Safety in MATINS Trial

Bexmarilimab KOL Event

Poster Presentations at AACR 2023

BEXMAB study update

Regulatory
PreviousNext
Back to top